Revolutionary Breakthrough: New Antimicrobial Wound Dressings Unveiled at EWMA 2024

Contributing to this year’s theme at the annual EWMA Conference, ‘Collaborative and Sustainable Wound Care’, experts from Avery Dennison Medical and Polaroid Therapeutics will lead an insightful discussion. Discover how partnership can bring a unique approach to antimicrobial wound dressings.

Antimicrobial Wound Dressings

Polaroid Therapeutics

The 20-minute session explores the synergy of Polaroid Therapeutics’ cutting-edge technology in the development of antimicrobial compounds and Avery Dennison Medical’s renowned expertise in materials science and wound care solutions, resulting in the creation of an innovative antimicrobial platform that elevates patient care and provides solutions to modern global health challenges.

Details of the session:

Title: Polaroid Therapeutics & Avery Dennison Medical: How the power of partnership brings a novel approach to antimicrobial wound dressings.

Speakers: Mr Ran Frenkel, CEO, Polaroid Therapeutics; and Dr. Emmett McArdle, Advanced Research and Development Manager at Avery Dennison Medical.

Date and time: Wednesday, May 1st, 2024, from 15:15 to 15:35.

Room: EWMA ARENA (E-Poster Area).

Conference venue: ExCeL London.

All participants to the EWMA Conference can attend this session, no prior registration is needed.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”